Description

Buy Authentic CJC-1295 NO DAC + Ipamorelin (10mg Blend) Online

Introduction

The CJC-1295 NO DAC + Ipamorelin Blend combines two peptides that are studied in endocrinology research for their effects on growth hormone release. CJC-1295 NO DAC is a GHRH analog, while Ipamorelin is a GHRP, or growth hormone releasing peptide. Together they are frequently used in laboratory models to study pulsatile GH secretion through two different receptor pathways.

CJC-1295 No DAC + Ipamorelin (10mg Blend) is a research-use-only peptide blend supplied for controlled laboratory workflows, multi-compound documentation review, and analytical characterization. This blend is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.

Key Product Details of CJC-1295 NO DAC + Ipamorelin (10mg Blend)

• Manufactured in accordance with rigorous quality standards to support ≥99% purity, as reflected in batch-specific documentation where available.
• Every batch is third-party analyzed for identity, assay/potency, and sterility documentation where applicable.
• Supplied in lyophilized powder form to help preserve stability throughout transport and storage.
• Produced with lot-level traceability to support research documentation and laboratory recordkeeping.
• Formulated as a multi-compound research blend containing CJC-1295 No DAC and Ipamorelin, 10mg total.

Research Documentation Context for CJC-1295 NO DAC + Ipamorelin (10mg Blend)

• Supports review of multi-compound blend composition in controlled laboratory settings.
• Provides batch-specific identity and purity documentation for research review.
• Allows lot-level traceability across laboratory documentation workflows.
• Supports comparison of product labeling, analytical documentation, and storage information during research planning.
• Assists researchers in evaluating individual component amounts within a clearly disclosed peptide blend.

Specifications and Documentation for CJC-1295 NO DAC + Ipamorelin (10mg Blend)

• Blend Composition: CJC-1295 No DAC + Ipamorelin, 10mg total.
• Certificate of Analysis: Available with batch-specific documentation where applicable.
• Material Safety Data Sheet: Coming Soon.
• Handling and Storage Instructions: Coming Soon.
• Product Form: Lyophilized powder.
• Purity Specification: ≥99% purity.
• Intended Use: Laboratory research use only.

CJC-1295 No DAC + Ipamorelin (10mg Blend) is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.This vial contains a total of *10mg* of combined peptide content in a CJC-1295 NO DAC + Ipamorelin blend for research use only. The exact ratio of each peptide is listed on the Certificate of Analysis. The product is supplied as lyophilized powder and requires reconstitution with bacteriostatic water prior to use in laboratory protocols. Proper handling and documentation should follow institutional guidelines.

Mechanism of Action

In preclinical research, CJC-1295 NO DAC binds to GHRH receptors in the pituitary to signal GH release. Ipamorelin binds to ghrelin receptors, also known as GHS-R1a, to stimulate a separate pulse of GH. Researchers examine the blend to understand how activating both pathways simultaneously may produce a synergistic effect on endogenous GH pulses in cell and animal models, without affecting other hormones like cortisol or prolactin in those studies.

Research Applications

Laboratory studies with this blend focus on metabolism, body composition models, sleep architecture, and recovery pathways. Scientists use it to investigate IGF-1 signaling, protein synthesis, and cellular repair mechanisms. The “NO DAC” version of CJC-1295 is specifically used when researchers want to study short, natural GH pulses rather than long-term elevation. All data to date is from research models, not human clinical trials.

Important Research Considerations

This blend is not a drug, supplement, or product approved for human use by the FDA or any regulatory agency. It is sold exclusively for in-vitro and animal research. Researchers must follow biosafety protocols, use appropriate PPE, and comply with all local regulations. Human safety, dosing, and efficacy have not been established, and long-term effects are unknown.

Storage and Handling

For best stability, store the unreconstituted blend at -20°C in a dry, dark environment. After reconstitution, aliquot into single-use portions and refreeze to avoid degradation from freeze-thaw cycles. Always use sterile technique when preparing solutions. This product is for research purposes only and is not intended to diagnose, treat, cure, or prevent any disease.